E3 Diabetes - Closing the Gap in Diabetes Control

Running, not enrolling · Not applicable

Conditions studied: Type 2 Diabetes

In brief

This study aims to decrease the racial gap in type 2 diabetes control in African American and Latinx patients in Rush University Medical Center clinics.

Key facts

Study ID

NCT06643936

Run by

Rush University Medical Center

People needed

150

Starts

2024-11-18

Expected to finish

2026-10-01

Last updated by the study team

2026-06-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults 18 years and older
• African American and/or Latinx
• Uncontrolled Type 2 Diabetes, A1C >/= 8.0 within the last 3 months
• Following with Rush primary care provider in eligible Rush primary care clinics
• Access to cellphone

You may not qualify if…

• Patient has Type 1 Diabetes
• Patient is already participating in another remote diabetes monitoring program
• Patient is not interested in participating in the program
• Patient has already participated in the E3 hypertension program

Where it is running

• Rush University Medical Center — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.